Article

Ultrasound in salivary gland disease.

Centre Antoine-Lacassagne Service de Radiologie, Nice, France.
ORL (Impact Factor: 1.1). 01/1993; 55(5):284-9. DOI: 10.1159/000276440
Source: PubMed

ABSTRACT This text reviews the normal ultrasound (US) anatomy of the salivary glands along with tumoral, lithiasic, and inflammatory pathologies. For salivary gland tumors, US does have limitations (failure to visualize the entire parotid gland, relations with the nerve plexus, in-depth spread of large tumors, false-negative errors of malignancy for small encapsulated tumors). However, US is a simple technique allowing correct identification of the benign nature of a lesion in over 80% of the cases. For lesions under 3 cm in diameter, US is generally the only imaging technique used; for larger lesions, CT or MR is required. Sialolithiasis and inflammatory diseases are being documented by US more and more and the indications for sialography have strongly decreased.

1 Bookmark
 · 
246 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background To evaluate the role of ultrasonography in the diagnosis of salivary gland masses. Materials and Methods The sonographic margin, internal texture, shape, and the clinical record of 25 cases (22 benign and 3 malignant) of verified salivary gland masses were retrospectively reviewed. Benign lesions included pleomorphic adenoma (n = 7), Warthin's tumor (n = 6), sclerosing sialadenitis (n = 5) including one associated with sialolithiasis, lymphoid hyperplasia (n = 2), and one case each of chronic suppurative inflammation with abscess and chronic inflammation. Malignancies included one case each of adenoid cystic carcinoma, squamous cell carcinoma and lymphoma. Results There was a significant difference in shape between the benign and malignant lesions (p = 0.037, oval or round versus irregular). Benign neoplasms and lymphoid hyperplasia were significantly more likely to be homogeneous with a well-defined margin and round or oval shape, while malignant and inflammatory lesions tended to be heterogeneous (p = 0.002) with indistinct margins (p = 0.001) and irregular shape (p = 0.009). A solid mass with small cysts was suggestive of Warthin's tumor. Conclusion Ultrasonography is a good imaging modality to assess salivary gland masses. It may help narrow the differential diagnoses and differentiate benign from malignant lesions.
    Journal of Medical Ultrasound 01/2003; 11(1):1-6.
  • [Show abstract] [Hide abstract]
    ABSTRACT: During a 6-year period we did a total of 72 videoendoscopies of the salivary glands and their associated ductal systems. This minimally invasive procedure is associated with little morbidity and discomfort. The main indication was sialolithiasis of the submandibular and parotid glands. Sialoendoscopy was used not only for diagnosis of radiolucent calculi but also for simultaneous removal of calculi. Sialoendoscopy was also of benefit in the diagnosis and treatment of other diseases of the salivary glands. Even patients with chronic sialadenitis could be helped with endoscopic dilatation of the causative sialostenosis, thereby enabling us to conserve the gland.
    British Journal of Oral & Maxillofacial Surgery - BRIT J ORAL MAXILLOFAC SURG. 01/2004; 42(1):1-7.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die Strategien zur Diagnostik und Behandlung von Parotistumoren scheinen in den deutschen HNO-Kliniken teilweise äußerst unterschiedlich zu sein. Ziel dieser Arbeit war es, mittels einer deutschlandweiten Umfrage einen Überblick über den derzeitigen Stand zu gewinnen.Allen deutschen HNO-Kliniken wurde postalisch ein standardisierter Fragebogen mit 19 Fragen zur Diagnostik und Behandlung von Parotistumoren zugesandt.Die Gesamtrücksendequote betrug 128 von 170 versandten Fragebögen (75%). Es bestätigte sich die Annahme, dass Parotistumoren in deutschen HNO-Kliniken sehr uneinheitlich behandelt werden.Auf der Grundlage der von uns erhobenen Daten und der ausstehenden Etablierung des klinischen Registers für Speicheldrüsenmalignome in Erlangen besteht Hoffnung, dass wichtige Fragen zur Behandlung von Speicheldrüsentumoren in naher Zukunft beantwortet werden können.
    HNO 11/2006; 54(11). · 0.42 Impact Factor